ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GWP GW Pharm.

735.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

GW Pharmaceuticals PLC Holding(s) in Company (8582E)

21/07/2016 10:08am

UK Regulatory


TIDMGWP

RNS Number : 8582E

GW Pharmaceuticals PLC

21 July 2016

 
 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
--------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                             GW Pharmaceuticals plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
--------------------------------------------------------------  ----------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                           X 
------------------------------------------------------------------  ------------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  ------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  ------------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  ------------------------------------- 
 Other (please 
  specify): 
--------------------------------------------------------  --------  ------------------------------------- 
 3. Full name of person(s)                                           The Capital Group Companies, 
  subject to the                                                                 Inc. 
  notification obligation: 
  (iii) 
----------------------------------------------------------  --------------------------------------------- 
 4. Full name of shareholder(s)                                             See Section 9 
  (if different from 3.):(iv) 
----------------------------------------------------------  --------------------------------------------- 
 5. Date of the transaction                                                  19 July 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
----------------------------------------------------------  --------------------------------------------- 
 6. Date on which issuer                                                     20 July 2016 
  notified: 
----------------------------------------------------------  --------------------------------------------- 
 7. Threshold(s) that is/are                                          Below 15% - aggregate of voting 
  crossed or                                                                 rights from shares 
  reached: (vi, vii) 
----------------------------------------------------------  --------------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------- 
 Class/type             Situation previous                Resulting situation after the 
  of                     to the triggering                 triggering transaction 
  shares                 transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
---------------------  --------------------------------  ---------------------------------------------------------------- 
                        Number           Number           Number         Number of               % of voting 
                         of               of               of shares      voting                  rights (x) 
                         Shares           Voting                          rights 
                                          Rights 
---------------------  ---------------  ---------------  -------------  ----------------------  ------------------------- 
                                                          Direct         Direct     Indirect     Direct        Indirect 
                                                                         (xi)        (xii) 
---------------------      -----------    -----------    -------------  ---------  -----------  ------------  ----------- 
         ADSs 
 (ISIN: US36197T1034)     3,323,774        39,885,288                               44,705,688                  14.8150% 
---------------------  ---------------  ---------------  -------------  ---------  -----------  ------------  ----------- 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------- 
 Type of financial          Expiration     Exercise/                       Number of voting          % of voting 
  instrument                 date           Conversion                      rights that               rights 
                             (xiii)         Period (xiv)                    may be 
                                                                            acquired if 
                                                                            the 
                                                                            instrument 
                                                                            is 
                                                                            exercised/ 
                                                                            converted. 
-------------------------  -------------  ------------------------------  ------------------------  --------------------- 
      Not applicable 
-------------------------  -------------  ------------------------------  ------------------------  --------------------- 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------- 
 Type of financial        Exercise       Expiration     Exercise/        Number of voting          % of voting 
  instrument               price         date           Conversion        rights instrument         rights (xix, 
                                         (xvii)         period            refers to                 xx) 
                                                        (xviii) 
-----------------------  -------------  -------------  ---------------  ------------------------  ----------------------- 
     Not applicable                                                                                Nominal       Delta 
-----------------------  -------------  -------------  ---------------  ------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                    Percentage of voting rights 
---------------------------------------------------------  -------------------------------------------------------------- 
                        44,705,688                                                    14.8150% 
---------------------------------------------------------  -------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
--------------------------------------------------------------------------------------------------- 
 
                                                 Number of        Percent 
                                                   Shares      of Outstanding 
    The Capital Group Companies, Inc. 
     ("CG") holdings                             44,705,688   14.8150% 
 
    Holdings by CG Management Companies 
     and Funds: 
   -------------------------------------------  -----------  ---------------- 
    -- Capital Research and Management 
     Company(1)                                  44,705,688   14.8150% 
 
          *    SMALLCAP World Fund, Inc.(2)      23,716,800           7.8595% 
 (1) Subsidiary of The Capital Group Companies, Inc. 
  (2) Mutual fund managed by Capital Research and Management 
  Company. 
--------------------------------------------------------------------------------------------------- 
 Proxy Voting: 
--------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
------------------------------------------------------------------------------  ------------------- 
 11. Number of voting rights proxy 
  holder will cease to hold: 
------------------------------------------------------------------------------  ------------------- 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
------------------------------------------------------------------------------  ------------------- 
 
 
  13. Additional information: 
------------------------------------------------------------------------------  ------------------- 
 14. Contact name:                                                               Christopher Aquino 
------------------------------------------------------------------------------  ------------------- 
 15. Contact telephone number:                                                     (213) 615-0469 
------------------------------------------------------------------------------  ------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEANXFAEXKEEF

(END) Dow Jones Newswires

July 21, 2016 05:08 ET (09:08 GMT)

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock